--- canonical_url: https://www.stockexpertai.com/earnings/ir last_updated: 2026-05-09T11:51:36.352Z --- # Ingersoll Rand Inc. (IR) Q4 FY2026 Earnings Preview > This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-09T11:51:35.789Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $75.75 (▼ -2.26%) | fmp:quote | | Market Cap | $29.6B | fmp:profile | | 52w range | $72.45 – $100.96 | fmp:quote | | Earnings | Thu 30 Jul | fmp:earnings-history | | EPS estimate | $0.83 (+4% YoY) | fmp:earnings-estimate | | Revenue estimate | $2.0B | fmp:earnings-estimate | | Beat streak | 2/4 | fmp:earnings-history | | Rating | B+ (overall 3/5) | fmp:ratings | | Analyst median target | $99 (+30.7% upside) | fmp:price-target-consensus | | MoonshotScore | 40/100 | derived | | Council | 3/6 bullish | derived | | Munger verdict | Undervalued | derived | ## Ingersoll Rand Inc. — Q4 FY2026 Expectations Q4 consensus: revenue $2.0B^{[FMP est]}, EPS $0.83^{[FMP est]}. 2 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** B+ · **Stance:** BUY · **Council:** 3/6 · **Moonshot:** 40 = MoonshotScore 40^{[9-pillar formula]} + Council 3/6^{[6-lens rule]}. Form 4: 0 transactions^{[FMP Form 4]}. ## Watchlist (6 metrics) ### 1. Pst Margin Improvement PST delivered adjusted EBITDA growth of 15% with a 120 basis points year-over-year margin improvement, reflecting continued strong operational execution. > "PST delivered adjusted EBITDA of $122 million, which was up 15% year-over-year. Adjusted EBITDA margins improved 120 basis points year-over-year, reflecting continued strong operational execution." > — Vicente Reynal, CEO, Risk Indicator · Q1 FY2026 ### 2. Organic Growth Outlook Ingersoll Rand expects organic growth of 1% for 2026. > "Total company revenue is expected to grow between 2.5% and 4.5%. And driven by organic growth of 1% at the midpoint" > — Vicente Reynal, CEO, Expectation / Guide · Q1 FY2026 ### 3. Its Order Growth ITS orders finished up 5% for the first quarter with a book-to-bill of 1.08x. > "ITS orders finished up 5% for the first quarter. Book-to-bill for the quarter was 1.08x." > — Vicente Reynal, CEO, Investor Focus · Q1 FY2026 ### 4. Full Year Guidance Reaffirmation Ingersoll Rand is reaffirming its full year 2026 revenue and EPS guidance. > "As we move to Slide 9, we are reaffirming our full year guidance for 2026." > — Vicente Reynal, CEO, Expectation / Guide · Q1 FY2026 ### 5. Fx Tailwind Ingersoll Rand expects FX to be a tailwind of approximately 0.5% in 2026. > "And finally, we expect FX to be a tailwind of approximately 0.5%." > — Vicente Reynal, CEO, Risk Indicator · Q1 FY2026 ### 6. M&A Contribution Ingersoll Rand expects approximately 2% revenue growth from completed acquisitions in 2026. > "growth from M&A of approximately 2%, which includes the carryover impact from all transactions completed as well as the recently announced signed transaction of funds." > — Vicente Reynal, CEO, Investor Focus · Q1 FY2026 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 0.0 | weak | Q1 vs Q2: growth negative (-2.2%, contraction) | | Gross Margin | 4.0 | medium | Q1: average margin (42.9%) | | Operating Leverage | 2.0 | weak | op margin healthy (15.7%) | | Cash Runway | 10.0 | strong | FCF very strong ($0.2B, 4.5× CapEx) | | R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) | | Price Momentum | 4.0 | medium | RSI 38.3 weak momentum, 50d below | | News Sentiment | 5.0 | medium | majority buy (50%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +30.7% | | Ken Griffin | bear | flow · 50d MA below | | Jim Simons | neutral | quant · RSI 38 | | Klarman | bull | value · target upside +30.7% | | Buffett | neutral | quality · ROE score 3/5 | | Munger | bull | valuation · target upside +30.7% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Undervalued - **Financial Health:** Moderate - **Margin of Safety:** Strong - **Interest Coverage:** Adequate - **ROIC vs WACC:** Tight **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 38.3 — momentum zayıf — oversold yakınında değil ama alıcı baskısı az - **50d MA:** $83 — hisse %8.9 altında — kısa vadeli direnç - **200d MA:** $83 — hisse %8.2 altında — uzun vadeli baskı - **Volume (10d):** -33% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q2 FY25 | $0.80 | $0.80 | BEAT | -11.4% | | Q3 FY25 | $0.86 | $0.86 | MISS | -3.0% | | Q4 FY25 | $0.96 | $0.91 | BEAT | +4.6% | | Q1 FY26 | $0.77 | $0.74 | +4.1% EPS | -4.6% | Q1 (April 29, 2026): EPS $0.77 vs $0.74 est^[FMP], +4.1% beat. D+1 movement: -4.6%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q4 EPS > $0.83 + CapEx discipline** Threshold: EPS > $0.83^{[FMP est]}. Target: Break above median target $99^{[FMP target]}; high target $110^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $0.83 + CapEx < $36.3M** Threshold: EPS ≈ $0.83^{[FMP est]}, Q4 CapEx < $36.3M^[FMP]. Target: Consolidation in the band between current $76^[FMP] and median $99^[FMP]. ### Scenario C · Miss **EPS < $0.81 or CapEx ≥ $36.3M** Threshold: EPS < $0.81^{[FMP est×0.97]}. Target: Current $76 below SMA200 $83^[FMP], if rejection continues, $70^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q1: EPS $0.77 vs $0.74 beat^[FMP], stock -4.6% D+1^[FMP]. ### Backlog concentration No RPO/backlog concentration disclosed in Q1 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26 ### CapEx shock Q1 CapEx $36.3M^{[FMP cashflow]}. Q1 op margin 15.7%^{[FMP op margin]} — this level in Q4 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $99 (+30.7% upside vs current $76) - **High / Low:** $110 / $90 - **Buy / Hold / Sell:** 8 / 8 / 0 - **Analyst count:** 6 (last quarter), 34 all-time ## Additional Transcript Insights ### 1. organic_growth_outlook **Claim:** Ingersoll Rand expects organic growth of 1% for 2026. **Evidence (transcript):** "Total company revenue is expected to grow between 2.5% and 4.5%. And driven by organic growth of 1% at the midpoint" **Numbers:** 2.5%, 4.5%, 1% ### 2. m&a_contribution **Claim:** Ingersoll Rand expects approximately 2% revenue growth from completed acquisitions in 2026. **Evidence (transcript):** "growth from M&A of approximately 2%, which includes the carryover impact from all transactions completed as well as the recently announced signed transaction of funds." **Numbers:** 2% ### 3. fx_tailwind **Claim:** Ingersoll Rand expects FX to be a tailwind of approximately 0.5% in 2026. **Evidence (transcript):** "And finally, we expect FX to be a tailwind of approximately 0.5%." **Numbers:** 0.5% ### 4. full_year_guidance_reaffirmation **Claim:** Ingersoll Rand is reaffirming its full year 2026 revenue and EPS guidance. **Evidence (transcript):** "As we move to Slide 9, we are reaffirming our full year guidance for 2026." **Numbers:** 2026 ### 5. its_order_growth **Claim:** ITS orders finished up 5% for the first quarter with a book-to-bill of 1.08x. **Evidence (transcript):** "ITS orders finished up 5% for the first quarter. Book-to-bill for the quarter was 1.08x." **Numbers:** 5%, 1.08 ### 6. pst_margin_improvement **Claim:** PST delivered adjusted EBITDA growth of 15% with a 120 basis points year-over-year margin improvement, reflecting continued strong operational execution. **Evidence (transcript):** "PST delivered adjusted EBITDA of $122 million, which was up 15% year-over-year. Adjusted EBITDA margins improved 120 basis points year-over-year, reflecting continued strong operational execution." **Numbers:** 15%, 120, 122 --- *Data source: FMP (live query, 2026-05-09), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*